HIV-1 Gag Conserved-Element DNA Vaccine (p24CE)

p24CE · National Institute of Allergy and Infectious Diseases (NIAID)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HIV-1 Gag Conserved-Element DNA Vaccine (p24CE), covering 2022-04-26 to 2022-04-26. Get the full timeline:

Most recent: Clinical Trial Update: HIV-1-Gag Conserved-Element DNA Vaccine (p24CE) Vaccine Study [Phase 1, Phase 2]